Facebook
Twitter
Telegram
Report an ErrorANI Pharmaceuticals Cash Flow 2011-2024 | ANIP
Annual Cash Flow ANI Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
119 M | -31.2 M | 3.32 M | 15.3 M | 45.6 M | 67.1 M | 39.4 M | 27.5 M | 17.3 M | 22 M | -5.48 M | -137 K | - |
Depreciation & Amortization |
59.8 M | 57 M | 47.3 M | 44.6 M | 44.6 M | 33.7 M | 27.9 M | 22.3 M | 6.9 M | 3.88 M | 1.11 M | 567 K | 148 K |
Accounts Payables |
36.7 M | 29.3 M | 23 M | 11.3 M | 14.6 M | 8.88 M | 3.63 M | 3.39 M | 2.07 M | 2.65 M | 1.43 M | 1.13 M | 3.15 M |
Accounts Receivables |
162 M | 165 M | 129 M | 95.8 M | 72.1 M | 64.8 M | 58.8 M | 45.9 M | 21.9 M | 17.3 M | 12.5 M | - | - |
Total Inventories |
111 M | 105 M | 81.7 M | 60.8 M | 48.2 M | 40.5 M | 37.7 M | 26.2 M | 13.4 M | 7.52 M | 3.52 M | - | - |
All numbers in USD currency
Quarterly Cash Flow ANI Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 21.4 M | - | -26.8 M | -30.4 M | -18.9 M | - | 15.5 M | 20.9 M | 20.7 M | - | 21 M | 22.6 M | 1.71 M | - | 40.8 M | 19 M | 14.3 M | - | 39.8 M | 31.5 M | 22.9 M | - | 23.6 M | 6.53 M | 6.53 M | - | 15.4 M | 14.3 M | 11 M | - | - | - | 1.12 M | - | 11.3 M | 7.13 M | 5.18 M | - | -2.62 M | - | - | - | 422 K | 556 K | - | - | - | - | - |
Depreciation & Amortization |
15.2 M | 14.7 M | 14.7 M | - | 14.2 M | 13.8 M | 14.6 M | - | 11.3 M | 11.3 M | 10.9 M | - | 11.4 M | 11.2 M | 11.2 M | - | 9.47 M | 9.47 M | 16.1 M | - | 8.55 M | 8.31 M | 8.2 M | - | 7.1 M | 7.1 M | 6.71 M | - | 5.97 M | 5.96 M | 4.61 M | - | 2.05 M | 1.42 M | 1.33 M | - | 1.19 M | 706 K | 703 K | - | 382 K | 147 K | 145 K | - | 144 K | 141 K | 30.9 K | - | 35.7 K | 40.5 K | 41.9 K |
Accounts Payables |
34.1 M | 28.5 M | 32.7 M | 29.3 M | 19 M | 27.6 M | 22.1 M | 23 M | 11.5 M | 13 M | 13.8 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 14.6 M | 14.6 M | 14.6 M | 14.6 M | 8.88 M | 8.88 M | 8.88 M | 8.88 M | 3.63 M | 3.63 M | 3.63 M | 3.63 M | 3.39 M | 3.39 M | 3.39 M | 3.39 M | 2.07 M | 2.07 M | 2.07 M | 2.07 M | 2.65 M | 2.65 M | 2.65 M | 2.65 M | 1.43 M | 1.43 M | 1.43 M | 1.43 M | 1.99 M | 1.99 M | 1.99 M | 1.13 M | 3.15 M | 3.15 M | 3.15 M | 3.15 M |
Accounts Receivables |
179 M | 173 M | 175 M | 165 M | 140 M | 150 M | 132 M | 129 M | 107 M | 92.6 M | 91.9 M | 95.8 M | 95.8 M | 95.8 M | 95.8 M | 72.1 M | 72.1 M | 72.1 M | 72.1 M | 64.8 M | 64.8 M | 64.8 M | 64.8 M | 58.8 M | 58.8 M | 58.8 M | 58.8 M | 45.9 M | 45.9 M | 45.9 M | 45.9 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 5.43 M | 5.43 M | 5.43 M | - | - | - | - | - |
Total Inventories |
107 M | 104 M | 104 M | 105 M | 95.9 M | 92.5 M | 83.2 M | 81.7 M | 61.7 M | 67.6 M | 59.9 M | 60.8 M | 60.8 M | 60.8 M | 60.8 M | 48.2 M | 48.2 M | 48.2 M | 48.2 M | 40.5 M | 40.5 M | 40.5 M | 40.5 M | 37.7 M | 37.7 M | 37.7 M | 37.7 M | 26.2 M | 26.2 M | 26.2 M | 26.2 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 7.52 M | 7.52 M | 7.52 M | 7.52 M | 3.52 M | 3.52 M | 3.52 M | 3.52 M | 2.81 M | 2.81 M | 2.81 M | - | - | - | - | - |
All numbers in USD currency